Acceleration of growth in Turner syndrome patients treated with growth hormone

Summary of three-year results

Ronald (Ron) Rosenfeld

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In 1983, a multicenter, collaborative prospective study was begun to investigate the efficacy of human growth hormone (hGH), alone and in combination with oxandrolone, in girls with Turner syndrome. While subjects in the control group grew 3.8 cm/yr (-0.1 SD for untreated Turner patients), subjects receiving hGH alone grew 6.6, 5.4 and 4.6 cm/yr in years 1-3, respectively (+3.1, +2.0, +1.4 SD). Subjects in the combination therapy group grew 9.8, 7.4 and 6.1 cm/yr (+6.6, +4.3, +3.0 SD). Turner subjects in both treatment groups showed increased in Bayley-Pinneau predicted adult heights and in Turner projected adult heights.

Original languageEnglish (US)
Pages (from-to)49-51
Number of pages3
JournalJournal of Endocrinological Investigation
Volume12
Issue number8 SUPPL. 3
StatePublished - 1989
Externally publishedYes

Fingerprint

Turner Syndrome
Human Growth Hormone
Growth Hormone
Oxandrolone
Group Psychotherapy
Growth
Prospective Studies
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Endocrinology

Cite this

Acceleration of growth in Turner syndrome patients treated with growth hormone : Summary of three-year results. / Rosenfeld, Ronald (Ron).

In: Journal of Endocrinological Investigation, Vol. 12, No. 8 SUPPL. 3, 1989, p. 49-51.

Research output: Contribution to journalArticle

@article{086420184da34fd2aa1c455e894906d6,
title = "Acceleration of growth in Turner syndrome patients treated with growth hormone: Summary of three-year results",
abstract = "In 1983, a multicenter, collaborative prospective study was begun to investigate the efficacy of human growth hormone (hGH), alone and in combination with oxandrolone, in girls with Turner syndrome. While subjects in the control group grew 3.8 cm/yr (-0.1 SD for untreated Turner patients), subjects receiving hGH alone grew 6.6, 5.4 and 4.6 cm/yr in years 1-3, respectively (+3.1, +2.0, +1.4 SD). Subjects in the combination therapy group grew 9.8, 7.4 and 6.1 cm/yr (+6.6, +4.3, +3.0 SD). Turner subjects in both treatment groups showed increased in Bayley-Pinneau predicted adult heights and in Turner projected adult heights.",
author = "Rosenfeld, {Ronald (Ron)}",
year = "1989",
language = "English (US)",
volume = "12",
pages = "49--51",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "8 SUPPL. 3",

}

TY - JOUR

T1 - Acceleration of growth in Turner syndrome patients treated with growth hormone

T2 - Summary of three-year results

AU - Rosenfeld, Ronald (Ron)

PY - 1989

Y1 - 1989

N2 - In 1983, a multicenter, collaborative prospective study was begun to investigate the efficacy of human growth hormone (hGH), alone and in combination with oxandrolone, in girls with Turner syndrome. While subjects in the control group grew 3.8 cm/yr (-0.1 SD for untreated Turner patients), subjects receiving hGH alone grew 6.6, 5.4 and 4.6 cm/yr in years 1-3, respectively (+3.1, +2.0, +1.4 SD). Subjects in the combination therapy group grew 9.8, 7.4 and 6.1 cm/yr (+6.6, +4.3, +3.0 SD). Turner subjects in both treatment groups showed increased in Bayley-Pinneau predicted adult heights and in Turner projected adult heights.

AB - In 1983, a multicenter, collaborative prospective study was begun to investigate the efficacy of human growth hormone (hGH), alone and in combination with oxandrolone, in girls with Turner syndrome. While subjects in the control group grew 3.8 cm/yr (-0.1 SD for untreated Turner patients), subjects receiving hGH alone grew 6.6, 5.4 and 4.6 cm/yr in years 1-3, respectively (+3.1, +2.0, +1.4 SD). Subjects in the combination therapy group grew 9.8, 7.4 and 6.1 cm/yr (+6.6, +4.3, +3.0 SD). Turner subjects in both treatment groups showed increased in Bayley-Pinneau predicted adult heights and in Turner projected adult heights.

UR - http://www.scopus.com/inward/record.url?scp=0024435254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024435254&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 49

EP - 51

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 8 SUPPL. 3

ER -